tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eddie Hickman, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).
Analyst Eddie Hickman, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 50% that have a potential upside of 78.05% achieved within 193 days.
Eddie Hickman’s has documented 31 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TARS, Tarsus Pharmaceuticals at 25-Feb-2026.
Analyst best performing recommendations are on ISEE (IVERIC BIO).
The best stock recommendation documented was for ISEE (IVERIC BIO) at 9/7/2022. The price target of $35 was fulfilled within 236 days with a profit of $20.06 (134.27%) receiving and performance score of 5.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-May-2023
$40
2 years 10 months 3 days ago
(08-May-2023)
4/5 (80%)
$8.4 (26.58%)
470
Hold Since 03-May-2023
$34
$-5.95 (-14.89%)
$26
2 years 10 months 8 days ago
(03-May-2023)
2/3 (66.67%)
$-3.21 (-8.63%)
116
Hold Since 02-May-2023
$35
$-4.95 (-12.39%)
$35
2 years 10 months 9 days ago
(02-May-2023)
5/6 (83.33%)
$-2.72 (-7.21%)
247
Hold Since 01-May-2023
$35
$-4.95 (-12.39%)
$29
2 years 10 months 10 days ago
(01-May-2023)
1/2 (50%)
$-3.05 (-8.02%)
15
Buy Since 07-Feb-2022
$35
$-4.95 (-12.39%)
$30
2 years 10 months 15 days ago
(24-Apr-2023)
3/3 (100%)
$3.34 (10.55%)
240
Which stock is Eddie Hickman is most bullish on?
Which stock is Eddie Hickman is most reserved on?
What Year was the first public recommendation made by Eddie Hickman?
